Trade Mark Journal No.2026/045 6 November 2026
WO0000001944949 (40)
Office of origin: China
Date of International Registration:3 August 2026
Date of designation in the UK:
3 August 2026

- Class 40
- Custom manufacturing of pharmaceuticals; processing and treating of chemical reagents; processing of medicinal materials; custom manufacturing of biopharmaceuticals; custom biomanufacturing of pharmaceuticals; custom manufacturing of cancer vaccines; providing information relating to material treatment; custom assembling of materials for others.
Nanjing GenScript Biotech Co., Ltd.
Representative: Linda Liu & Partners, F16 Tower C, Beijing Global Trade Center,, 36 North Third Ring East Road,, Dongcheng District, 100013 Beijing, CHINA